<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04982406</url>
  </required_header>
  <id_info>
    <org_study_id>2020P001189</org_study_id>
    <nct_id>NCT04982406</nct_id>
  </id_info>
  <brief_title>Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System</brief_title>
  <acronym>TAVR-HBE</acronym>
  <official_title>Transcatheter Aortic Valve Replacement (TAVR) Effects on Cardiac Conduction System</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Beth Israel Deaconess Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Beth Israel Deaconess Medical Center</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a prospective observational study, the purpose of which is to:&#xD;
&#xD;
        1. Characterize response of the AV conduction system to TAVR with various prostheses by&#xD;
           recording continuous His bundle electrograms during valve placement.&#xD;
&#xD;
        2. Correlate preprocedure ECG features with changes in AV nodal and infranodal conduction&#xD;
           during placement of the valve prosthesis.&#xD;
&#xD;
        3. Correlate changes in AV nodal and infranodal conduction during the procedure with risk&#xD;
           of developing AV conduction block after TAVR.&#xD;
&#xD;
        4. Assess the contribution of stressing the conduction system by atrial pacing prior to and&#xD;
           following TAVR to prediction of postprocedural heart block.&#xD;
&#xD;
      Assess the correlation between new onset bundle branch block, site and degree of conduction&#xD;
      block or delay and subsequent development of high-grade or complete AV block.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Study Population:&#xD;
&#xD;
      Inclusion criteria -all patients undergoing elective TAVR Exclusion criteria -patients with&#xD;
      permanent implanted pacemakers or ICDs prior to TAVR&#xD;
&#xD;
        1. Record standard 12-lead ECG prior to procedure.&#xD;
&#xD;
        2. Place standard electrode catheter via a venous sheath prior to TAVR&#xD;
&#xD;
        3. Initially place the catheter in a proximal position with a large atrial electrogram and&#xD;
           proximal His electrogram.&#xD;
&#xD;
        4. Record baseline His bundle electrogram. Record baseline AH and HV intervals.&#xD;
&#xD;
        5. Pace the atrium starting at a cycle length 100 ms shorter than the sinus cycle length,&#xD;
           progressively reducing the paced cycle length in 20 ms decrements after 3 seconds pacing&#xD;
           at each cycle length, while continuously monitoring arterial blood pressure, to A-V&#xD;
           block.&#xD;
&#xD;
        6. Advance the distal electrodes while maintaining recording of a His bundle electrogram to&#xD;
           a position where stable right ventricular pacing is secured. Record the RV pacing&#xD;
           threshold.&#xD;
&#xD;
        7. If a stable right ventricular pacing position together with stable His bundle&#xD;
           electrogram cannot be achieved, a second venous temporary pacing wire will be placed.&#xD;
&#xD;
        8. Record presence or absence of retrograde conduction during RV pacing at 4 times pacing&#xD;
           threshold.&#xD;
&#xD;
        9. Ensure stable continuous His bundle electrogram recording while the aortic valve&#xD;
           prosthesis is deployed.&#xD;
&#xD;
       10. Use the distal electrodes for rapid ventricular pacing at 4 times threshold during&#xD;
           deployment of the valve prosthesis.&#xD;
&#xD;
       11. After the prosthesis has been deployed and is deemed stable, just prior to removing the&#xD;
           RV catheter, record a final HBE (AH, HBE, SCL) and again pull back catheter to enable&#xD;
           atrial capture with proximal electrodes - pace as above to AV block: start starting at a&#xD;
           cycle length 100 ms shorter than the sinus cycle length, progressively reducing the&#xD;
           paced cycle length in 20 ms decrements after 3 seconds pacing at each cycle length while&#xD;
           monitoring continuous arterial blood pressure to A-V block.&#xD;
&#xD;
       12. Record 12-lead ECG after completion of the procedure and daily thereafter until hospital&#xD;
           discharge.&#xD;
&#xD;
       13. Standard telemetry monitoring post procedure while hospitalized.&#xD;
&#xD;
       14. Upon hospital discharge place a standard continuous ambulatory ECG monitor for 2 weeks&#xD;
           in patients that do not have a pacemaker implanted.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 18, 2021</start_date>
  <completion_date type="Anticipated">May 18, 2022</completion_date>
  <primary_completion_date type="Anticipated">May 18, 2022</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>1 Month</target_duration>
  <primary_outcome>
    <measure>Heart block</measure>
    <time_frame>30 days following procedure</time_frame>
    <description>Development of heart block requiring permanent pacemaker implantation</description>
  </primary_outcome>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Aortic Stenosis</condition>
  <condition>Transcatheter Aortic Valve Replacement</condition>
  <condition>Heart Block</condition>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Transcatheter aortic valve replacement</intervention_name>
    <description>Transcatheter aortic valve replacement</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with severe aortic stenosis or regurgitation planned to undergo transcatheter&#xD;
        aortic valve replacement&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients undergoing elective TAVR at BIDMC&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  patients with permanent implanted pacemakers or ICDs prior to TA&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alfred Buxton, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beth Israel Deaconess Medical Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Alfred E Buxton, MD</last_name>
    <phone>617-632-9209</phone>
    <email>abuxton@bidmc.harvard.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Roger Laham, MD</last_name>
    <phone>617-632-7597</phone>
    <email>rlaham@bimc.harvard.edu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Alfred Buxton</name>
      <address>
        <city>Needham</city>
        <state>Massachusetts</state>
        <zip>02492</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alfred Buxton, MD</last_name>
      <phone>617-632-9209</phone>
      <email>abuxton@bidmc.harvard.edu</email>
    </contact>
    <contact_backup>
      <last_name>Roger Laham, MD</last_name>
      <phone>617-632-7597</phone>
      <email>rlaham@bidmc.harvard.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Alfred E Buxton, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Roger Haham, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Duane Pinto, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Mark Tuttle, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marie-France Poulin, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Louis Chu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>David Liu, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Venkatachalam Senthilnathan, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Beatie Ultimo, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Kim Guibone, NP</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Andre D'Avila, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Patricia Tung, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Jonathan Waks, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 20, 2021</study_first_submitted>
  <study_first_submitted_qc>July 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 29, 2021</study_first_posted>
  <last_update_submitted>July 20, 2021</last_update_submitted>
  <last_update_submitted_qc>July 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 29, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Beth Israel Deaconess Medical Center</investigator_affiliation>
    <investigator_full_name>Alfred Buxton</investigator_full_name>
    <investigator_title>Shlomo Ben-Haim, MD - Mark E. Josephson, MD, Professor of Medicine in Field of Cardiac Electrophysiology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aortic Valve Stenosis</mesh_term>
    <mesh_term>Heart Block</mesh_term>
    <mesh_term>Cardiac Conduction System Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>Global Results will be published, not individual patient data</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

